Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chi

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Hepatology International|September 10, 2013
Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assayWai-Kay Seto, Yasuhito Tanaka, Danny Ka-Ho Wong, et al.
Hepatology (Baltimore, Md.)|March 17, 2012
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearanceWai-Kay Seto, Danny Ka-Ho Wong, James Fung, et al.
Environmental Research|January 14, 2023
Insect biorefinery: A circular economy concept for biowaste conversion to value-added productsPhei Er Kee, Yu-Shen Cheng, Jo-Shu Chang, et al.
The American Journal of Gastroenterology|September 28, 2004
Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis BMan-Fung Yuen, Irene Oi-Lin Ng, Sheung-Tat Fan, et al.
Carcinogenesis|April 20, 2004
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control studyMan-Fung Yuen, Yasuhito Tanaka, Masashi Mizokami, et al.
BMC Infectious Diseases|February 11, 2022
Spontaneous intramedullary abscesses caused by Streptococcus anginosus: two case reports and review of the literatureChristian D Cerecedo-Lopez, Joshua D Bernstock, Adam A Dmytriw, et al.
Antiviral Therapy|February 5, 2008
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced diseaseMan-Fung Yuen, Wai-Kay Seto, Danny Hoi-Fan Chow, et al.
Respiratory Care|April 27, 2022
Respiratory Therapist-Driven Extubation Readiness Testing in a Single Pediatric ICUHerng Lee Tan, Yi-Jyun Ma, Apollo Bugarin Aguilan, et al.
Journal of Hepatology|October 22, 2003
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutationsMan-Fung Yuen, Takanobu Kato, Masashi Mizokami, et al.
Plos One|June 11, 2014
Artificial neural network accurately predicts hepatitis B surface antigen seroclearanceMing-Hua Zheng, Wai-Kay Seto, Ke-Qing Shi, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Hepatology International|September 10, 2013
Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assayWai-Kay Seto, Yasuhito Tanaka, Danny Ka-Ho Wong, et al.
Hepatology (Baltimore, Md.)|March 17, 2012
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearanceWai-Kay Seto, Danny Ka-Ho Wong, James Fung, et al.
Environmental Research|January 14, 2023
Insect biorefinery: A circular economy concept for biowaste conversion to value-added productsPhei Er Kee, Yu-Shen Cheng, Jo-Shu Chang, et al.
The American Journal of Gastroenterology|September 28, 2004
Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis BMan-Fung Yuen, Irene Oi-Lin Ng, Sheung-Tat Fan, et al.
Carcinogenesis|April 20, 2004
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control studyMan-Fung Yuen, Yasuhito Tanaka, Masashi Mizokami, et al.
BMC Infectious Diseases|February 11, 2022
Spontaneous intramedullary abscesses caused by Streptococcus anginosus: two case reports and review of the literatureChristian D Cerecedo-Lopez, Joshua D Bernstock, Adam A Dmytriw, et al.
Antiviral Therapy|February 5, 2008
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced diseaseMan-Fung Yuen, Wai-Kay Seto, Danny Hoi-Fan Chow, et al.
Respiratory Care|April 27, 2022
Respiratory Therapist-Driven Extubation Readiness Testing in a Single Pediatric ICUHerng Lee Tan, Yi-Jyun Ma, Apollo Bugarin Aguilan, et al.
Journal of Hepatology|October 22, 2003
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutationsMan-Fung Yuen, Takanobu Kato, Masashi Mizokami, et al.
Plos One|June 11, 2014
Artificial neural network accurately predicts hepatitis B surface antigen seroclearanceMing-Hua Zheng, Wai-Kay Seto, Ke-Qing Shi, et al.
Pageof 15